Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
BioMarin Scheduled to Participate in March Investor Conferences | ||||||||||||
By: PR Newswire Association LLC. - 01 Mar 2024 | Back to overview list |
|||||||||||
- Cowen 44th Annual Healthcare Conference on March 5 SAN RAFAEL, Calif., March 1, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced management is scheduled to participate in four upcoming investor conferences in March. Cowen 44th Annual Healthcare Conference (Boston, MA)
Leerink Partners Global BioPharma Conference (Miami, FL)
Jefferies Biotech on the Bay Summit (Miami, FL)
Barclays 26th Annual Global Healthcare Conference (Miami, FL)
The live webcast of the fireside chat can be accessed by visiting BioMarin's website at https://investors.biomarin.com/. A webcast replay will be available through the Company's website for a limited time following the conferences. About BioMarin Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of the genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-scheduled-to-participate-in-march-investor-conferences-302077029.html SOURCE BioMarin Pharmaceutical Inc. |
||||||||||||
|
||||||||||||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |